Lee JonesFounder, President and CEO at Rebiotix Inc., USA
Founder, President and CEO of Rebiotix Inc, has over 30 years of experience in the medical technology industry in large and small companies and academia. She cofounded Rebiotix in 2011. Rebiotix is a clinical stage biotechnology company developing a new class of biologic drugs based on live human-derived microbes. The company was acquired by Ferring Pharmaceuticals in Apr 2018. Previously, she was Chief Administrative Officer of the Schulze Diabetes Institute at the University of Minnesota and is the former president and chief executive officer of Inlet Medical. Prior to Inlet, she spent 14 years at Medtronic where she developed and commercialized several innovative products. Lee is serving on several boards and is an advisor to small companies. Ms. Jones has a BS in Chemical Engineering and an Executive Management degree from the University of Minnesota.